Literature DB >> 30900813

Invasive fusariosis masquerading as extramedullary disease in rapidly progressive acute lymphoblastic leukemia.

John A Ligon1,2, Mukil Natarajan3, Haneen Shalabi2, Bonnie Yates2, Rachel Bishop4, David Bianchi5, Alvaro Alencar6, Michail S Lionakis3, Nirali N Shah2.   

Abstract

Invasive fusariosis (IF) most commonly occurs in patients with hematologic malignancies and severe neutropenia, particularly during concomitant corticosteroid use. Breakthrough infections can occur in high-risk patients despite Aspergillus-active antifungal prophylaxis. We describe a patient with rapid acute lymphoblastic leukemia (ALL) progression who presented with multifocal skin nodules thought to be choloromatous disease. These lesions were ultimately diagnosed as IF and the patient had two simultaneously active disease processes. This case highlights the importance of pathologic diagnosis of new skin lesions in ALL patients, even during leukemia progression, and demonstrates that IF can occur despite normal neutrophil counts and Aspergillus-active prophylaxis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fusarium; acute lymphoblastic leukemia; immunocompromised; invasive fungal infection

Mesh:

Year:  2019        PMID: 30900813      PMCID: PMC8237328          DOI: 10.1002/pbc.27732

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  23 in total

1.  Cutaneous involvement with B-lineage acute lymphoblastic leukemia.

Authors:  Chadi Nabhan; Angelica Tolentino; Andrew Meyer; Martin S Tallman
Journal:  Leuk Lymphoma       Date:  2011-12-05

2.  Improvement in the outcome of invasive fusariosis in the last decade.

Authors:  M Nucci; K A Marr; M J G T Vehreschild; C A de Souza; E Velasco; P Cappellano; F Carlesse; F Queiroz-Telles; D C Sheppard; A Kindo; S Cesaro; N Hamerschlak; C Solza; W J Heinz; M Schaller; A Atalla; S Arikan-Akdagli; H Bertz; C Galvão Castro; R Herbrecht; M Hoenigl; G Härter; N E U Hermansen; A Josting; L Pagano; M J C Salles; S B Mossad; D Ogunc; A C Pasqualotto; V Araujo; P F Troke; O Lortholary; O A Cornely; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2013-11-18       Impact factor: 8.067

3.  Fusarium infections in critically ill patients.

Authors:  Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Semin Respir Crit Care Med       Date:  2004-04       Impact factor: 3.119

Review 4.  Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.

Authors:  Ilaria Rizzello; Fausto Castagnetti; Pier Giorgio Toschi; Patrizia Bertaccini; Laura Primavera; Michela Paolucci; Luca Faccioli; Luca Spinardi; Russell E Lewis; Michele Cavo; Marta Stanzani
Journal:  Mycoses       Date:  2017-09-22       Impact factor: 4.377

Review 5.  Glucocorticoids and invasive fungal infections.

Authors:  Michail S Lionakis; Dimitrios P Kontoyiannis
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

6.  Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.

Authors:  Marcio Nucci; Elias J Anaissie; Flavio Queiroz-Telles; Carlos A Martins; Plínio Trabasso; Cristiana Solza; Claudia Mangini; Belinda P Simões; Arnaldo L Colombo; Jorge Vaz; Carlos E Levy; Silvia Costa; Vaneusa A Moreira; José Salvador Oliveira; Nestor Paraguay; Gisele Duboc; Julio C Voltarelli; Angelo Maiolino; Ricardo Pasquini; Cármino A Souza
Journal:  Cancer       Date:  2003-07-15       Impact factor: 6.860

Review 7.  Taxonomy, biology, and clinical aspects of Fusarium species.

Authors:  P E Nelson; M C Dignani; E J Anaissie
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 8.  Leukemia cutis.

Authors:  Jeong Hee Cho-Vega; L Jeffrey Medeiros; Victor G Prieto; Francisco Vega
Journal:  Am J Clin Pathol       Date:  2008-01       Impact factor: 2.493

9.  Outcomes after induction failure in childhood acute lymphoblastic leukemia.

Authors:  Martin Schrappe; Stephen P Hunger; Ching-Hon Pui; Vaskar Saha; Paul S Gaynon; André Baruchel; Valentino Conter; Jacques Otten; Akira Ohara; Anne Birgitta Versluys; Gabriele Escherich; Mats Heyman; Lewis B Silverman; Keizo Horibe; Georg Mann; Bruce M Camitta; Jochen Harbott; Hansjörg Riehm; Sue Richards; Meenakshi Devidas; Martin Zimmermann
Journal:  N Engl J Med       Date:  2012-04-12       Impact factor: 91.245

10.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

Authors:  A M Tortorano; M Richardson; E Roilides; A van Diepeningen; M Caira; P Munoz; E Johnson; J Meletiadis; Z-D Pana; M Lackner; P Verweij; T Freiberger; O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; J Guinea; J Guarro; S de Hoog; W Hope; S Kathuria; O Lortholary; J F Meis; A J Ullmann; G Petrikkos; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.